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Clinical background
Obesity has reached pandemic dimensions and novel
pharmacological therapies are urgently needed. Obesity
is characterized by excessive fat storage in white adipose
tissue (WAT), because of a positive energy balance. In
contrast to WAT, brown adipose tissue (BAT) dissipates
energy and produces heat – a process known as non-
shivering thermogenesis. To identify novel BAT-
centered antiobesity therapies, we studied the role of
soluble guanylyl cyclase (sGC) in BAT. sGC produces
the second messenger cyclic GMP (cGMP) after stimu-
lation with nitric oxide.
Here, we used a small molecule that stimulates sGC in
a heme–dependent manner. Treatment of mice with the
sGC stimulator during a high fat diet protected against
weight gain and improved metabolic changes. Notably,
stimulation of sGC induced weight loss also in already
established obesity. Mechanistically, the sGC stimulator
enhanced expression of thermogenic genes and induced
“browning” (i.e. the expression of brown adipocyte-
specific markers) of murine and human adipocytes. sGC
stimulation increased lipid uptake into BAT, and caused
an increase in whole body energy expenditure.
Conclusion
Taken together, sGC is a potential pharmacological tar-
get for the treatment of obesity and its comorbidities.
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